The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: Prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels

被引:112
作者
Cattaneo, M
Chantarangkul, V
Taioli, E
Santos, JH
Tagliabue, L
机构
[1] Univ Milan, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Inst Internal Med, I-20122 Milan, Italy
[2] Univ Milan, IRCCS, Osped Maggiore, Milan, Italy
关键词
deep-vein thrombosis; factor V Leiden; prothrombin; methylenetetrahydrofolate reductase; risk factor; homocysteine;
D O I
10.1016/S0049-3848(98)00136-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A common G to A transition at nucleotide 20210 of the prothrombin gene is associated with an increased risk for deep-vein thrombosis (DVT) and high plasma levels of prothrombin. We calculated the prevalences of prothrombin G20210A, factor V G1691A (also associated with high risk for DVT) and homozygous methylenetetrahydrofolate reductase (MTHFR) C677T (associated with increased susceptibility to develop hyperhomocysteinemia) in 118 patients with a first episode of DVT and in 416 healthy controls. 15.9% of the patients and 2.3% of the controls had prothrombin G20210A (odds ratio [OR]: 8.7, 95% C.I.: 3.8-21.4); 21.1% of the patients and 3.2% of the controls had factor V G1691A (OR 7.8, 3.9-17.1); 20.5% of the patients and 21% of the controls had homozygous MTHFR C677T (OR: 1.0, 0.7-1.2). Exclusion of patients with other hereditary risk factors for DVT did not substantially modify the results. Mutant factor V and prothrombin coexisted in three patients but in no control. The concomitant presence of the MTHFR mutation did not increase the thrombotic risk associated with prothrombin G20210A. 63.2% of individuals with prothrombin G20210A had plasma levels of prothrombin in the upper quartile of distribution. After adjustment for age and sex, subjects with prothrombin levels in the upper quartile carried a slightly higher risk for thrombosis than those with lower prothrombin concentrations (OR: 1.9, 1.1-3.2). In conclusion, we found that prothrombin G20210A is relatively common in Italy and is associated with high prothrombin levels and an 8.7-fold increase in the risk for DVT. Such risk is independent of the coexistence of other known inherited risk factors for thrombosis and increases in patients with associated mutant factor V. Whether it is due to the associated increase in plasma prothrombin levels remains to be established. (C) 1998 Elsevier Science Ltd.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 34 条
[1]   The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gln mutation in thrombophilic families [J].
AlhencGelas, M ;
LeCamDuchez, V ;
Emmerich, J ;
Frebourg, T ;
Fiessinger, JN ;
Borg, JY ;
Aiach, M .
BLOOD, 1997, 90 (04) :1711-1711
[2]  
Arruda VR, 1997, THROMB HAEMOSTASIS, V78, P1430
[3]  
Arruda VR, 1997, THROMB HAEMOSTASIS, V77, P818
[4]  
BERTINA RM, 1979, THROMB HAEMOSTASIS, V42, P1296
[5]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[6]   Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene [J].
Brown, K ;
Luddington, R ;
Williamson, D ;
Baker, P ;
Baglin, T .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (04) :907-909
[7]   A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (Factor V:Q(506)) [J].
Cattaneo, M ;
Tsai, MY ;
Bucciarelli, P ;
Taioli, E ;
Zighetti, ML ;
Bignell, M ;
Mannucci, PM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) :1662-1666
[9]   The venous thrombosis risk factor 20210 A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease [J].
Corral, A ;
GonzalezConejero, R ;
Lozano, ML ;
Rivera, J ;
Heras, I ;
Vicente, V .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :304-307
[10]   The prothrombin gene G20210A variant: Prevalence in a UK anticoagulant clinic population [J].
Cumming, AM ;
Keeney, S ;
Salden, A ;
Bhavnani, M ;
Shwe, KH ;
Hay, CRM .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :353-355